This trial is testing a drug to see if it can lower the level of metals in the bone marrow and blood of patients with leukemia or myelodysplastic syndrome, and if it helps control the disease or improves response to chemotherapy.
2 Primary · 0 Secondary · Reporting Duration: Up to the end of cycle 1 (each cycle is 28 days)
58 Total Participants · 2 Treatment Groups
Primary Treatment: Multivitamin · No Placebo Group · Phase 1
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: